Tag Archive

The following is a list of all entries tagged with Phase I designes:

Comments (1)

New Microdosing / Expolaratory drug studies – Phase I clinical Trials.

Filed in clinical,regulatory, March 19, 2009, 3:49 pm , ,

One of my Colleagues Dr Anthony Lockett recently attended a presentation by David R. Jones an expert scientific assessor (Pharmacotoxicologist) at the MHRA who gave a very useful update on the area of safety testing with regard to Phase I studies. One of the topics under discussion was Microdosing in Phase 1 clinical trials. There [...]